Evaluating human papillomavirus vaccination programs

Sex Transm Dis. 2013 Apr;40(4):290-1. doi: 10.1097/OLQ.0b013e318282d69b.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cost-Benefit Analysis
  • Female
  • Humans
  • Immunization Programs* / economics
  • Male
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines* / economics
  • Program Evaluation
  • Public Health
  • Uterine Cervical Neoplasms / prevention & control*

Substances

  • Papillomavirus Vaccines